mms prassad koppolu

In his role as Corporate Advisor, Prasad will continue to advise on strategic direction, and optimize growth and scale across all global locations.

Prasad has demonstrated a successful track record of senior leadership in complex, global, customer-focused organizations. He recognizes the strength and value that exceptional talent brings to our business and service functions while applying the best practices from ISO certifications and principles. He also leads infrastructure expansion, supporting the company’s projected growth and driving improved global connectivity.

Diversity is the most powerful force in the world. We all come from different backgrounds, and the differences that we have are used in a positive, unified way to assist sponsors in making the world a better place. Diversity of skills, talent, and experiences is our strength, and we are proud of it.
Prasad M. Koppolu
Corporate Advisor

Prasad has more than 25 years of experience across a diverse group of industries, including technology, transportation, energy, and professional services. He has held senior leadership positions in business development, operations, and research and development, among others.

Prasad earned his master’s degrees in industrial engineering and mechanical engineering from Clarkson University in New York and the Indian Institute of Technology.

Suggested For You

news

April 3rd, 2025

Datacise by MMS Wins 2025 Data Breakthrough Award for Best Data Science Solution

perspectives

March 27th, 2025

Enhancing Drug Safety Through Digital Solutions: Innovative Technologies in FDA REMS Programs

news

March 19th, 2025

MMS REMS-focused Technology bolsters Full-Service REMS Solutions

webinar

April 30th, 2025

Advancing Clinical Development with Innovative Trial Design and Regulatory Strategies

perspectives

March 6th, 2025

Overview of FDA Guidance for Industry on Assessment of Ovarian Toxicity in Premenopausal Adults During Development for Oncologic Products

webinar

March 25th, 2025

Overcoming NDA/BLA Submission Challenges: Practical Strategies for Success

perspectives

February 13th, 2025

Helping European Drug Development Companies Succeed in the US Market

news

February 12th, 2025

MMS Acquires Exploristics and KerusCloud Simulation Platform to Expand Biostatistics and Data Science Capabilities as a Global Data-Focused CRO

perspectives

January 30th, 2025

Post-PDUFA VII Updates: FDA Meetings Public Workshop & Lessons Learned

perspectives

January 21st, 2025

REMS Modifications and Revisions: A Retrospective from the Past 12 Months

regulatory intelligence

January 17th, 2025

The FDA’s AI Guidance and its Seven Steps into the Future of Drug Development

regulatory intelligence

January 17th, 2025

New FDA Protocol Deviation Guidance:  Planning for the Things That Don’t Go According to Plan